about
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?Fatty acids as biocompounds: their role in human metabolism, health and disease: a review. part 2: fatty acid physiological roles and applications in human health and disease.Xanthomas: clinical and pathophysiological relations.Pleiotropic effects of niacin: Current possibilities for its clinical use.The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids.Plasma Phospholipid Fatty Acid Profile is Altered in Both Septic and Non-Septic Critically Ill: A Correlation with Inflammatory Markers and Albumin.Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin.Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins.Hypolipidemic drugs can change the composition of rat brain lipids.Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study.The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress.Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects.Fatty Acid Composition of Plasma Phosphatidylcholine Determines Body Fat Parameters in Subjects with Metabolic Syndrome-Related Traits.Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot studyImprovements in colorectal cancer screening programmes - quantitative immunochemical faecal occult blood testing - how to set the cut-off for a particular populationLeptin and adiponectin in pancreatic cancer: connection with diabetes mellitusResting energy expenditure and thermal balance during isothermic and thermoneutral haemodialysis heat production does not explain increased body temperature during haemodialysisOmega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese miceGlucose tolerance, insulin secretion, plasma lipid fatty acids, and the hypolipidemic effects of fish oilRelationships between fatty acid composition and insulin-induced oxidizability of low-density lipoproteins in healthy menIncreased lipoprotein oxidability and aortic lipid peroxidation in an experimental model of insulin resistance syndromeEffect of column and software on gas chromatographic determination of fatty acidsHigher content of 18:1 trans fatty acids in subcutaneous fat of persons with coronarographically documented atherosclerosis of the coronary arteriesSeverity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in menEffects of dietary n-3 fatty acids on the composition of cholesteryl esters and triglycerides in plasma and liver perfusate of the ratStatin use and serum bilirubin levelsAntioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitisPlasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parametersLipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up StudyFish oil supplementation with various lipid emulsions suppresses in vitro cytokine release in home parenteral nutrition patients: a crossover studyElevation of high density lipoproteins in acromegalics after lisuride treatment
P50
Q26799534-F2C27F63-2C01-4D10-A0D8-146D22A3B549Q37979687-EFC25824-49EF-40FC-8DEE-0DDDFA9E9816Q38208169-F78E34A4-E0C6-4FF2-ABD1-8927B8EF9980Q38810790-36013BEA-0AF8-42CD-9E69-8BBABDE69847Q39162778-C378FA2A-BB48-46DA-B810-3F8DF34EDAE0Q39787343-7D1080E8-66D7-4FBA-B4FA-7ED64FEA0C32Q40389776-E7A93EDB-2398-4E4B-AB59-61C6778953F1Q40976509-4B9458F5-5CC0-4062-8303-829C0A9DC618Q43096148-0336FA1E-39EF-49AA-8E12-4827B0B7AC1EQ43903897-6A6CDB5B-631F-4B53-B5CD-4D7D379CDAECQ45169031-148DC3D2-CB69-4929-9CCC-A50920ECF1A6Q46157931-B99438AE-48A0-4984-9955-919B3F74B121Q46749686-5A47B48A-9ACD-4EB3-ABB9-AAE5824D4610Q49594620-D6AB9BC1-BC3A-4DA3-A511-7359F91B8E4DQ53152255-9FE2CB20-F847-43F3-A49D-F2DCAE3CBBE1Q57825151-B4761488-F1E2-4547-AEFC-7FC6CA3F7CADQ57825161-A625DB1E-F15C-4C54-8109-07978D312CE8Q57825188-8CD09E7A-7A7D-4D5E-9C1B-36CBF186B65CQ57825340-4008CE67-8E7D-45BA-90DC-7BEF387617BCQ59607817-3D80034D-FCA3-4982-900F-F33C2B067EDDQ72882557-21934A1A-DC81-442B-8084-AA62C47FEDCDQ73786533-EBF4EF2F-2F91-4171-B71D-C2FD80A79F30Q73786618-29DF8065-B856-4580-B48F-B78BF1D884A0Q74106575-EC26014F-D56A-4EF7-9974-B4C76F2A9E1AQ79102467-F4A9B8DE-CD3A-4D36-AE22-6D1572060513Q80694388-BD6F5BEE-F9FA-4ECC-A7B7-F835F2541472Q80991384-9D4237A8-D6C2-4867-B50B-8DDED733181FQ85046441-F587C74B-8097-4889-B9D8-FB2F077CDDC4Q86543225-ABCB9DC3-1E2C-4946-A23C-A28A19DBD13FQ87436709-C223C87E-4D3F-4C48-9419-F9678950CAA0Q88175117-B33DFE54-C2FB-4DB6-BD41-F34399C6D777Q91413376-21E7C826-B827-4A38-88D7-3FEC476FFB59Q93574476-D458D15A-C577-49F5-A343-1EBD2F2C950B
P50
description
gastroenterolog
@cs
researcher ORCID ID = 0000-0002-1698-6068
@en
name
Ales Zak
@ast
Ales Zak
@es
Ales Zak
@nl
Aleš Žák
@cs
Aleš Žák
@en
type
label
Ales Zak
@ast
Ales Zak
@es
Ales Zak
@nl
Aleš Žák
@cs
Aleš Žák
@en
prefLabel
Ales Zak
@ast
Ales Zak
@es
Ales Zak
@nl
Aleš Žák
@cs
Aleš Žák
@en
P214
P1153
7102520669
P19
P21
P214
P31
P496
0000-0002-1698-6068
P569
1951-05-25T00:00:00Z
P691
mzk2007382175
P734
P735
P7859
lccn-n2010183751